SOURCE: Advanced Plant Pharmaceuticals, Inc.

February 06, 2007 15:24 ET

Advanced Plant Pharmaceuticals, Inc. in Advanced Stage Negotiations for $1.25 Million in Financing for Construction of Biodiesel Plants

Pending Agreement to Include Long-Term Lease of Plant Sites

NEW YORK, NY -- (MARKET WIRE) -- February 6, 2007 -- Advanced Plant Pharmaceuticals, Inc. (OTCBB: APPI) announced today the company is in advanced stage negotiations for the necessary financing to construct two biodiesel plants with one plant in Kentucky to provide biofuel to a dedicated and committed customer and the other plant to be constructed in Florida.

The pending agreement includes a long-term lease of property for the biodiesel plants. As previously announced, the biodiesel plant in Kentucky is for a coal mine which will require 4-5 thousand gallons a day. The company has forecasted the first plant's revenue run rate at APPI $1 Million quarterly after the plant has completed its first full quarter of operation. An additional site is planned in the State of Florida with similar favorable long-term leasing options and state tax incentives. The company will announce the financing closing and construction start dates in the near future.

Advanced Plant Pharmaceuticals, Inc. has previously announced that the company's board of directors had adopted a resolution to change the corporate name to World Health Energy, Inc., to reflect the company's acquisition of World Health Energy, Inc. and the new business plan's focus on biofuels and renewable energy production and distribution. The company anticipates the name change will be completed within sixty days. A new ticker symbol to reflect the corporate name of World Health Energy, Inc. will be issued after the name change has been approved. World Health Energy, Inc. plans to use renewable cost-effective agricultural products both domestically and internationally to develop natural alternative fuels.

An 8-K for the merger with World Health Energy will be filed after the satisfaction of the closing conditions which include, without limitation, issuance and receipt of all consideration relating to the transaction and other customary closing conditions.

To be added to Advanced Plant Pharmaceutical's corporate e-mail list for shareholders and interested investors, please send an e-mail to

About World Health Energy, Inc.

World Health Energy, Inc. is a renewable energy company focused on developing and producing alternative fuels. WHE's proposed biodiesel production plants are designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214, as well as ASTM D6751 specifications.

About Advanced Plant Pharmaceuticals, Inc.

Advanced Plant Pharmaceuticals, Inc. (APPI) has focused on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol™ worldwide through various sales distribution channels. The company is currently in the initial stages of shifting its business plan to enter the rapidly growing renewable energy market.

"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995

This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.

Contact Information